Psoriasis News and Research

Latest Psoriasis News and Research

Scientists make breakthrough in understanding how inflammation is regulated

Scientists from Trinity College Dublin have made an important breakthrough in understanding how inflammation is regulated. They have just discovered that a key immune alarm protein previously believed to calm down the immune response actually does the opposite.

16 Dec 2022

Extraordinary plasticity of the glucocorticoid receptor revealed

Glucocorticoids —such as cortisone— are among the most widely used anti-inflammatory drugs, and are used to treat asthma, psoriasis, organ transplantation and even COVID-19.

15 Dec 2022

TYK2 inhibitor identifies as a promising drug candidate for preventing type 1 diabetes

According to a study, type 1 diabetes could be prevented by inhibiting a gene associated with the onset of the disease.

10 Nov 2022

Multiple research platforms identify environmental chemical agents that promote intestinal inflammation

Inflammatory bowel disease (IBD), a condition characterized by chronic gastrointestinal inflammation, is becoming increasingly common in industrialized countries.

21 Oct 2022

Does skin inflammation exacerbate COVID-19?

In a new study, researchers discussed inflammation during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Oct 2022

People with end-stage renal disease and psoriasis do not have increased risk for heart attack

Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators have made the surprising finding that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not.

18 Oct 2022

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

A new review discussed the applications of single-cell ribonucleic acid sequencing (scRNA-seq) in understanding autoimmune disorders.

17 Oct 2022

Immune-mediated inflammatory diseases following COVID-19

Researchers explore the potential association between SARS-CoV-2 infection and immune-mediated inflammatory diseases.

12 Oct 2022

Thirdhand smoke exposure elevates biomarkers associated with the initiation of skin diseases

Thirdhand smoke, or THS, comprises the residual pollutants from tobacco smoke that remain on surfaces and in dust after tobacco has been smoked.

11 Oct 2022

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Researchers evaluated the efficacy of the anti-inflammatory drug dimethyl fumarate in treating COVID-19 as part of an early phase, randomized, controlled assessment trial in the UK.

28 Sep 2022

Studies explore how differences in skin composition may lead to dermatological conditions

Why are certain body parts more prone to skin diseases than others? Two new UC Davis Health studies explored how differences in skin composition may lead to dermatological conditions, such as psoriasis and atopic dermatitis.

23 Sep 2022

Patients with autoimmune diseases at greater risk of complications after heart attack

In a recent study published in the Journal of the American Heart Association, researchers assessed midterm and management outcomes of acute myocardial infarction (AMI) among patients with rheumatic immune-mediated inflammatory diseases (IMIDs).

18 Sep 2022

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Around ten percent of the population in high income regions like Europe and the United States has been diagnosed with one or multiple autoimmune disorders.

29 Aug 2022

Scientists begin phase 2 clinical trials of lupus pill

Lupus is an autoimmune disease that attacks organs and can be fatal. There's no cure, so current treatments aim to limit damage and ameliorate symptoms.

22 Aug 2022

Epidural lidocaine injections show promise for treating psoriasis

Psoriasis is a chronic inflammatory, debilitating skin disorder. Although there is no cure for psoriasis, several treatment options can inhibit inflammation and relieve signs and symptoms of this disease.

10 Aug 2022

Clinical and demographic inequalities in COVID-19-associated mortality

Researchers quantified the relative and absolute changes in COVID-19-related mortality based on clinical and demographical profiles of 18 million adult patients throughout the pandemic in England.

4 Aug 2022

Three things about the abortion debate that many people get wrong

In the wake of the Supreme Court's decision to overturn the federal right to abortion, things are more than a little confused.

22 Jul 2022

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

Around 250,000 people in Austria suffer from psoriasis. One third of them develop inflammation in their joints (psoriatic arthritis) as a result of the chronic skin condition.

6 Jul 2022

The potential mechanisms of SARS-CoV-2 to induce DNA damage

Researchers described potential mechanisms of coronaviruses that could lead to DNA damage and the potential link between SARS-CoV-2 activity and such mechanisms.

14 Jun 2022

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Researchers assessed the risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immunomodulatory therapies.

13 Jun 2022

Psoriasis News and Research

Latest Psoriasis News and Research

Scientists make breakthrough in understanding how inflammation is regulated

Extraordinary plasticity of the glucocorticoid receptor revealed

TYK2 inhibitor identifies as a promising drug candidate for preventing type 1 diabetes

Multiple research platforms identify environmental chemical agents that promote intestinal inflammation

Does skin inflammation exacerbate COVID-19?

People with end-stage renal disease and psoriasis do not have increased risk for heart attack

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Immune-mediated inflammatory diseases following COVID-19

Thirdhand smoke exposure elevates biomarkers associated with the initiation of skin diseases

Study finds dimethyl fumarate was not associated with an improvement in clinical outcomes in adults hospitalized with COVID-19

Studies explore how differences in skin composition may lead to dermatological conditions

Patients with autoimmune diseases at greater risk of complications after heart attack

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Scientists begin phase 2 clinical trials of lupus pill

Epidural lidocaine injections show promise for treating psoriasis

Clinical and demographic inequalities in COVID-19-associated mortality

Three things about the abortion debate that many people get wrong

Scientists discover a key starting point for inhibiting inflammation in psoriasis and psoriatic arthritis

The potential mechanisms of SARS-CoV-2 to induce DNA damage

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Psoriasis News and Research

Latest Psoriasis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in